1Raptopoulou A,Sidiropoulos P,Katsouraki M. Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis:evolving concepts[J].Critical Reviews in Clinical Laboratory Sciences,2007.339-363. 被引量:1
7van Vollenhoven R F, Severens J L. Observational studies: a valua- ble source for data on the true value of RA therapies[ J]. Clin Rheu- matol, 2011,30 ( 1 ) : S19- S24. 被引量:1
8Karkucak M, Capkin E, Ozsu S, et al. An evaluation ofthe tubercu- lin skin test for anti TNF alpha prophylaxis in patients with ankylo-sing spondylitis and rheumatoid arthritis [ J ]. Bratisl Lek Listy, 2010, 111 (9) :498-501. 被引量:1
9Shirinskii I V, Zheltova 0 I, Shirinskii V S, et al. Relationship be- tween blood lipid spectrum and activity ofthe disease in patients with rheumatoid arthritis[J]. Klin Med ( Mosk), 2008,86(12) :40-43. 被引量:1
10Kiely P, Walsh D, Williams R,et al. Outcome in rheumatoid arthri- tis patients with continued conventional therapy for moderate disease activity-theearly RA network ( ERAN ) [ J ]. Rheumatology ( Ox- ford), 2011,50(5) :926-931. 被引量:1